Resources

In part 5, the conclusion, of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about care for the prediabetes patient and the importance of doctors conveying the severity of the situation.

In part 6, the conclusion, of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about her presentation goals for the provider audience.

Drs. Sood and Messer discuss the takeaways from their presentation with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas. They also share the advantages of working for a large organization versus private practice.

In this week's Homerun Slides, schema of the action of the Glycocalyx.

Insulin sensitivity based upon the OGTT: The previous discussion suggests that “quick and dirty” indices from fasting values may not be accurate, and it is often true that laboratory procedures are impractical. Recently, it has been suggested that indices calculated from the OGTT may be useful for population studies. For decades the OGTT has been used as a screening test and a diagnostic tool for diabetes and IGT. It might be ideal if one could classify the state of carbohydrate tolerance and simultaneously measure insulin sensitivity and beta-cell function.

Semaglutide trumps Trulicity in most recent trial.

The evolution of metformin therapy through the decades.

Diabetic foot ulcers put patients at increased risk of falling.

CKD risk not necessarily tied to albuminuria in patients with type 1 diabetes.

Lowering HbA1c worth the risk of urinary tract and genital infections?